WAVE Life Sciences Ltd.
WVE
$5.56
-$0.52-8.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -69.36M | -26.09M | -53.18M | -53.85M | -50.47M |
| Total Depreciation and Amortization | 2.37M | 2.31M | 2.26M | 2.23M | 2.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.67M | 9.06M | 7.35M | 6.47M | 6.20M |
| Change in Net Operating Assets | 2.74M | -44.83M | 9.79M | 484.00K | -3.94M |
| Cash from Operations | -53.58M | -59.55M | -33.78M | -44.67M | -46.01M |
| Capital Expenditure | -884.00K | -438.00K | 1.00K | -248.00K | -306.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -122.57M | -- | -- | -- | -- |
| Cash from Investing | -123.45M | -438.00K | 1.00K | -248.00K | -306.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 330.00K | 2.53M | 392.76M | 32.69M | 11.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 46.94M | -- | -- |
| Cash from Financing | 330.00K | 2.53M | 439.70M | 32.69M | 11.69M |
| Foreign Exchange rate Adjustments | 123.00K | -4.00K | -60.00K | -29.00K | 43.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -176.58M | -57.47M | 405.86M | -12.25M | -34.58M |